Home › Funds › AQR Capital Management › STRO
AQR Capital Management position in STRO
SUTRO BIOPHARMA INC · Health Care
Latest position (Q1 2026)8.61K sh
Reported value held$214.35K
Portfolio Weight0.00%
First reportedQ3 2021
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 14.52K | $274.00K | New |
| Q1 2022 | 23.18K | $191.00K | New |
| Q2 2022 | 59.40K | $309.00K | Add |
| Q3 2022 | 192.08K | $1.07M | Add |
| Q4 2022 | 198.11K | $1.60M | Add |
| Q1 2023 | 393.70K | $1.82M | Add |
| Q2 2023 | 81.70K | $379.91K | Reduce |
| Q3 2023 | 23.76K | $82.44K | Reduce |
| Q4 2023 | 83.63K | $358.76K | Add |
| Q1 2024 | 35.82K | $202.39K | Reduce |
| Q2 2024 | 283.52K | $830.70K | Add |
| Q3 2024 | 325.54K | $1.13M | Add |
| Q4 2024 | 114.59K | $210.84K | Reduce |
| Q1 2025 | 1.32M | $859.39K | Add |
| Q2 2025 | 1.01M | $722.98K | Reduce |
| Q3 2025 | 354.45K | $307.80K | Reduce |
| Q4 2025 | 18.03K | $208.65K | Reduce |
| Q1 2026 | 8.61K | $214.35K | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding STRO
- BlackRock Inc 1.12M sh · $37.27M · Q2 2026
- Balyasny Asset Management 711.16K sh · $23.61M · Q2 2026
- Geode Capital Management 389.69K sh · $12.94M · Q2 2026
- Millennium Management 365.97K sh · $12.15M · Q2 2026
- Point72 Asset Management 237.83K sh · $7.90M · Q2 2026
- UBS Group AG 208.51K sh · $6.92M · Q2 2026
- Two Sigma Investments 201.69K sh · $6.70M · Q2 2026
- Marshall Wace 175.25K sh · $5.82M · Q2 2026
- JPMorgan Chase & Co 159.63K sh · $5.32M · Q2 2026
- Goldman Sachs Group 149.22K sh · $4.95M · Q2 2026
- Vanguard Group 375.79K sh · $4.35M · Q4 2025
- Northern Trust Corp 125.93K sh · $4.18M · Q2 2026